Gateway Investment Advisers LLC lowered its stake in shares of Mylan NV (NASDAQ:MYL) by 5.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,281 shares of the company’s stock after selling 1,254 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Mylan were worth $575,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in MYL. Pinnacle Bank boosted its holdings in Mylan by 66.4% in the first quarter. Pinnacle Bank now owns 1,060 shares of the company’s stock worth $30,000 after purchasing an additional 423 shares during the period. Kinneret Advisory LLC acquired a new position in Mylan in the fourth quarter worth $71,000. First Hawaiian Bank boosted its holdings in Mylan by 560.4% in the fourth quarter. First Hawaiian Bank now owns 2,886 shares of the company’s stock worth $79,000 after purchasing an additional 2,449 shares during the period. NuWave Investment Management LLC boosted its holdings in Mylan by 18.1% in the fourth quarter. NuWave Investment Management LLC now owns 3,136 shares of the company’s stock worth $86,000 after purchasing an additional 480 shares during the period. Finally, FNY Investment Advisers LLC boosted its holdings in Mylan by 42.8% in the fourth quarter. FNY Investment Advisers LLC now owns 3,300 shares of the company’s stock worth $90,000 after purchasing an additional 989 shares during the period. 83.68% of the stock is owned by institutional investors and hedge funds.
In related news, insider Paul Campbell sold 11,533 shares of Mylan stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $27.50, for a total value of $317,157.50. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.81% of the company’s stock.
Shares of Mylan stock opened at $26.73 on Thursday. The company has a current ratio of 1.39, a quick ratio of 0.83 and a debt-to-equity ratio of 1.17. Mylan NV has a 52 week low of $26.00 and a 52 week high of $42.50. The stock has a market capitalization of $13.97 billion, a price-to-earnings ratio of 5.84, a price-to-earnings-growth ratio of 1.13 and a beta of 1.48.
Mylan (NASDAQ:MYL) last issued its quarterly earnings results on Tuesday, February 26th. The company reported $1.30 EPS for the quarter, missing the consensus estimate of $1.36 by ($0.06). Mylan had a return on equity of 19.06% and a net margin of 3.08%. The business had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.10 billion. During the same quarter last year, the firm posted $1.43 earnings per share. Mylan’s revenue was down 4.8% compared to the same quarter last year. As a group, analysts predict that Mylan NV will post 4.38 earnings per share for the current year.
MYL has been the subject of several analyst reports. Mizuho reissued a “neutral” rating on shares of Mylan in a report on Thursday, January 31st. Morgan Stanley raised shares of Mylan from an “equal weight” rating to an “overweight” rating and set a $35.00 price target for the company in a report on Wednesday, March 6th. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Mylan from a “buy” rating to a “hold” rating in a report on Monday, January 14th. Credit Suisse Group restated a “buy” rating and set a $37.00 price objective on shares of Mylan in a research note on Wednesday, March 6th. Finally, Cantor Fitzgerald restated a “hold” rating and set a $41.00 price objective on shares of Mylan in a research note on Monday, April 1st. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $39.89.
TRADEMARK VIOLATION WARNING: “Mylan NV (MYL) Stake Decreased by Gateway Investment Advisers LLC” was first published by Macon Daily and is the property of of Macon Daily. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://macondaily.com/2019/04/18/mylan-nv-myl-stake-decreased-by-gateway-investment-advisers-llc.html.
Mylan Company Profile
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS.
Recommended Story: Growth Stocks
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.